Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study

BACKGROUND: Checkpoint inhibitors in melanoma can lead to self-immune side-effects such as vitiligo-like depigmentation (VLD). Beyond the reported association with favorable prognosis, there are limited data regarding VLD patient features and their echo on the therapeutic outcomes. METHODS: To asses...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESMO Open
Autors principals: Guida, M., Strippoli, S., Maule, M., Quaglino, P., Ramondetta, A., Chiaron Sileni, V., Antonini Cappellini, G., Queirolo, P., Ridolfi, L., Del Vecchio, M., Cocorocchio, E., Di Giacomo, A.M., Festino, L., Merelli, B., Occelli, M., Brugnara, S., Minisini, A., Sava, S., Tommasi, S., De Summa, S.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7970061/
https://ncbi.nlm.nih.gov/pubmed/33711672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100064
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars